Nutlin-3a Efficacy in Sarcoma Predicted by Transcriptomic and Epigenetic Profiling

Kathleen I Pishas; Susan J Neuhaus; Mark T Clayer; Andreas W Schreiber; David M Lawrence; Michelle Perugini; Robert J Whitfield; Gelareh Farshid; Jim Manavis; Steve Chryssidis; Bronwen J Mayo; Rebecca C Haycox; Kristen Ho; Michael P Brown; Richard J D'Andrea; Andreas Evdokiou; David M Thomas; Jayesh Desai; David F Callen; Paul M Neilsen

Journal article

Nutlin-3a Efficacy in Sarcoma Predicted by Transcriptomic and Epigenetic Profiling

Kathleen I Pishas, Susan J Neuhaus, Mark T Clayer, Andreas W Schreiber, David M Lawrence, Michelle Perugini, Robert J Whitfield, Gelareh Farshid, Jim Manavis, Steve Chryssidis, Bronwen J Mayo, Rebecca C Haycox, Kristen Ho, Michael P Brown, Richard J D'Andrea, Andreas Evdokiou, David M Thomas, Jayesh Desai, David F Callen, Paul M Neilsen

Cancer Research | AMER ASSOC CANCER RESEARCH | Published : 2014

DOI: 10.1158/0008-5472.CAN-13-2424

University of Melbourne Researchers

Jayesh Desai Author The Sir Peter MacCallum Department of Oncology

Kathleen Pishas Author The Sir Peter MacCallum Department of Oncology

Grants

Awarded by Cancer Australia

Funding Acknowledgements

This study was supported by the ASSG Sarcoma Research Award funded through the Rainbows for Kate Foundation in memory of Tom Wood, Florey Medical Research Foundation, Royal Adelaide Hospital Research Foundation, Freemasons Trevor Prescott Memorial Scholarship, Cancer Australia (APP1034715), and Cure Cancer Australia Foundation. M. Perugini acknowledges financial contributions from the Fred Shahin Early-Career Fellowship.